BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19841608)

  • 1. Alternative dosage of zidovudine in infants exposed to maternal human immunodeficiency virus infection.
    Frasca K; Fisher RG; McGuire E
    Pediatr Infect Dis J; 2009 Dec; 28(12):1131-2. PubMed ID: 19841608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators.
    Lallemant M; Jourdain G; Le Coeur S; Kim S; Koetsawang S; Comeau AM; Phoolcharoen W; Essex M; McIntosh K; Vithayasai V
    N Engl J Med; 2000 Oct; 343(14):982-91. PubMed ID: 11018164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.
    Wade NA; Birkhead GS; Warren BL; Charbonneau TT; French PT; Wang L; Baum JB; Tesoriero JM; Savicki R
    N Engl J Med; 1998 Nov; 339(20):1409-14. PubMed ID: 9811915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of perinatal transmission with treatment combinations of intrapartum and newborn zidovudine monotherapy.
    Patchen L; Khoshnood K
    AIDS Read; 2001 May; 11(5):269-77. PubMed ID: 11392696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of short-course zidovudine to prevent perinatal transmission of human immunodeficiency virus in rural Kenya.
    Songok EM; Fujiyama Y; Tukei PM; Vulule JM; Kiptoo MK; Adungo NO; Kakimoto K; Kobayashi N; Genga IO; Mpoke S; Ichimura H
    Am J Trop Med Hyg; 2003 Jul; 69(1):8-13. PubMed ID: 12932089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapartum and neonatal zidovudine treatment in reduction of perinatal HIV-1 transmission in Bangkok.
    Thaithumyanon P; Thisyakorn U; Limpongsanurak S; Chaithongwongwatthana S; Punnahitanon S; Ubolyam S; Phanuphak P; Ruxrungtham K; Virutamasen P
    J Med Assoc Thai; 2001 Sep; 84(9):1229-34. PubMed ID: 11800293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.
    Limpongsanurak S; Thaithumyanon P; Chaithongwongwatthana S; Thisyakorn U; Ruxrungtham K; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P; Virutamasen P; Hanwanich M; Hawanon P; Chulasugondha P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S338-45. PubMed ID: 11529355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants.
    Prasitwattanaseree S; Lallemant M; Costagliola D; Jourdain G; Mary JY
    Antivir Ther; 2004 Apr; 9(2):179-85. PubMed ID: 15134179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
    Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M
    Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen.
    Lahoz R; Noguera A; Rovira N; Català A; Sánchez E; Jiménez R; Fortuny C
    Pediatr Infect Dis J; 2010 Apr; 29(4):376-9. PubMed ID: 19949355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados.
    St John AM; Kumar A; Cave C
    Pediatr Infect Dis J; 2003 May; 22(5):422-6. PubMed ID: 12792382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of oral zidovudine administered during labour: a preliminary study.
    Mirochnick M; Rodman JH; Robbins BL; Fridland A; Gandía J; Hitti J; Bardeguez A; Rathore MH; Gonzalez Garcia A; Cababasay M; Samson P; Mofenson L; Bryson YJ; Dorenbaum A
    HIV Med; 2007 Oct; 8(7):451-6. PubMed ID: 17760737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
    Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
    Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No adverse effects in infants following short-course zidovudine.
    AIDS Read; 2001 Feb; 11(2):81. PubMed ID: 11279877
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventing vertical transmission of HIV infection.
    Peckham C; Newell ML
    N Engl J Med; 2000 Oct; 343(14):1036-7. PubMed ID: 11018171
    [No Abstract]   [Full Text] [Related]  

  • 18. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(8):151-4. PubMed ID: 9518278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reducing perinatal transmission by antiretroviral therapy].
    Schmied B
    Wien Med Wochenschr; 1998; 148(23-24):550-5. PubMed ID: 10189685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.